NET PROFIT (x1000 EUR)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 EUR)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-18
|
-17
|
-28 |
| EBITDA |
-18
|
-17
|
-28 |
| Total assets |
17
|
13
|
21 |
| Current assets |
17
|
13
|
21 |
| Current liabilities |
3
|
6
|
7 |
| Equity capital |
14
|
7
|
15 |
| - share capital |
10
|
13
|
13 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
82.4%
|
53.8%
|
71.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-105.9%
|
-130.8%
|
-133.3% |
| Current ratio |
566.7%
|
216.7%
|
300% |
| Return on equity (ROE) |
-128.6%
|
-242.9%
|
-186.7% |
| Change turnover |
0
|
0
|
-72 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.